Pricing
Prices are indicative MRP and may vary by pharmacy. Trend compares against the last recorded price.
All price changes →Dizuva
Rx1 mg+100 mg • Capsule
Indications & Uses
Dizuva capsule is indicated for use during continuous combined Hormone Replacement Therapy (HRT) for estrogen deficiency symptoms in postmenopausal women with an intact uterus and with at least 12 months since last menses.
Dosage Reference
Reference Information Only
Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.
Adults:
Adult: Take a single capsule orally each evening with food.Pediatrics: This capsule has not been studied in this patient population and is not recommended for use.Geriatrics: This capsule has not been studied in this patient population and is not recommended for use.Hepatic Insufficiency: This capsule is contraindicated in women with liver dysfunction or disease as long as liver function tests have failed to return to normal.Renal Insufficiency: This capsule is to be used with caution in women with renal dysfunction.
Side Effects
Common: Alopecia, nausea, abdominal pain, headache, fatigue, flatulence, dizziness, vaginal hemorrhage, vaginal discharge, uterine spasm, pelvic pain and breast pain.Rare: Ear swelling, vertigo, hirsutism, dry eye, vision blurred, visual impairment, vitreous floaters, cholelithiasis, unstable angina.
Cautions & Contraindications
Warnings & Precautions
Women using HRT sometimes experience increased blood pressure. Blood pressure should be monitored with HRT use. Elevation of blood pressure in previously normotensive or hypertensive patients should be investigated and HRT may have to be discontinued. Estrogens with or without progestins may cause fluid retention. Therefore, particular caution is indicated in cardiac or renal dysfunction or asthma.Patients who develop visual disturbances, classical migraine, transient aphasia, paralysis or loss of consciousness should discontinue medication.
Contraindications
Hypersensitivity to this drug or to any ingredient in the formulation, including any non-medicinal ingredient or component of the container, patients with liver dysfunction or disease where liver function tests have failed to return to normal, history of estrogen-dependent or progestogen dependent malignant neoplasia, patients with endometrial hyperplasia, undiagnosed abnormal genital bleeding, pregnancy, breastfeeding, history of arterial thromboembolic disease, patients with classical migraine